LPTI (Longport) Days Payable: 0.00 (As of . 20)


What is Longport Days Payable?

Longport LPTI -99.00% Days Payable is 0.00 as of . 20.

Longport's average Accounts Payable for the three months ended in . 20 was $0.00 Mil. Longport's Cost of Goods Sold for the three months ended in . 20 was $0.00 Mil.

The historical rank and industry rank for Longport's Days Payable or its related term are showing as below:

LPTI's Days Payable is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 67.97
* Ranked among companies with meaningful Days Payable only.

Longport's Days Payable stayed the same from . 20 (0.00) to . 20 (0.00). stayed the same

Longport Days Payable Historical Data

* Premium members only.

The historical data trend for Longport's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Longport Days Payable Chart

Longport Annual Data
Trend
Days Payable

Longport Quarterly Data
Days Payable

LPTI vs PSID, GBSN, ETAH: Days Payable Comparison

For the Medical Devices subindustry, Longport's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Longport Days Payable vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Longport's Days Payable distribution charts can be found below:

* The bar in red indicates where Longport's Days Payable falls into.


Longport Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Longport's Days Payable for the fiscal year that ended in . 20 is calculated as

Days Payable (A: . 20 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: . 20 ) + Accounts Payable (A: . 20 )) / count ) / Cost of Goods Sold (A: . 20 )*Days in Period
=( ( + ) / 1 ) / *365
=0 / *365
=N/A

Longport's Days Payable for the quarter that ended in . 20 is calculated as:

Days Payable (Q: . 20 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: . 20 ) + Accounts Payable (Q: . 20 )) / count ) / Cost of Goods Sold (Q: . 20 )*Days in Period
=( ( + ) / 1 ) / *365 / 4
=0 / *365 / 4
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Days Payable →
What does a Days Payable of 0.00 mean?
Longport (LPTI) has a Days Payable of 0.00 as of . 20. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Longport and its competitors.
Is Longport's Days Payable too high?
Longport's current Days Payable is 0.00.
How does Longport's Days Payable compare to PSID and GBSN?
Longport's Days Payable of 0.00 can be compared against companies in the Medical Devices & Instruments industry. The industry median Days Payable is 67.97. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 67.97, based on 794 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Longport and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 67.97 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Longport's current Days Payable is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Longport stock overvalued right now?
Longport (LPTI) has a current Days Payable of 0.00. The current Days Payable is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Longport (LPTI), the current Days Payable is 0.00 as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Longport Business Description

Address 1620 Baltimore Pike, P.O. Box 768, Chadds Ford, PA, USA, 19317
Longport Inc is focused on developing, manufacturing, marketing, and selling high resolution ultrasound imaging systems. The company's applications serve the following market sectors: Wound assessment and prevention, Dermatology, Aesthetics, and Research, including validation of processes and products that impact the skin.